| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |